Presentations
Here, you will find presentations and webcasts from financial reports, as well as key press and investor events.
2026
Financial reports presentations
| Sobi's Q1 2026 report, 28 april | ||
| Sobi's Q4 2025 report, 5 February |
Investor meetings presentations
| Capital Markets Day 2026 |
2025
Financial reports presentations
| Sobi's Q3 2025 report, 20 October | ||
| Sobi's Q2 2025 report, 16 July | ||
| Sobi's Q1 2025 report, 29 April | ||
| Sobi's Q4 2024 report, 5 February |
2024
Financial reports presentations
| Sobi's Q3 2024 report, 24 October | ||
| Sobi's Q2 2024 report, 16 July | ||
| Sobi's Q1 2024 report, 25 April | ||
| Sobi's Q4 2023 report, 8 February |
Investor meetings presentations
| VALIANT Phase 3 results, 29 October |
2023
Financial reports presentations
| Sobi's Q3 2023 report, 30 October | ||
| Sobi's Q2 2023 report, 18 July | ||
| Sobi's Q1 2023 report, 27 April | ||
| Sobi's Q4 2022 report, 8 February |
2022
Financial reports presentations
| Sobi's Q3 2022 report, 27 October | ||
| Sobi's Q2 2022 report, 19 July | ||
| Sobi's Q1 2022 report, 28 April | ||
| Sobi's Q4 2021 report, 10 February |
2021
Financial reports presentations
| Sobi's Q2 2021 report, 21 July | ||
| Sobi's Q1 2021 report, 4 May | ||
| Sobi's Q4 2020 report, 18 February |
2020
Financial reports presentations
| Sobi's Q3 2020 report, 22 October | ||
| Sobi's Q2 2020 report, 16 July | ||
| Sobi's Q1 2020 report, 29 April | ||
| Sobi's Q4 2019 report, 13 February |
Investor meetings presentations
| Capital markets day, 10 December | ||
| Licensing of Aspaveli/Empaveli, 27 October | ||
| Capital markets day, 10 December (video) |
2019
Financial reports presentations
| Sobi's Q3 2019 report, 31 October | ||
| Sobi's Q2 2019 report, 17 July | ||
| Sobi's Q1 2019 report, 25 April | ||
| Sobi's Q4 2018 report, 20 February |
Investor meetings presentations
| Acquisition of Dova Pharmaceuticals, Inc., 30 September | ||
| Capital markets day, 14 May |
2018
Financial reports presentations
| Sobi's Q3 2018 report, 31 October | ||
| Sobi's Q2 2018 report, 18 July | ||
| Sobi's Q1 2018 report, 26 April | ||
| Sobi's Q4 2017 report, 22 February |
Investor meetings presentations
| Acquisition of Synagis, 13 November |
2017
Financial reports presentations
| Sobi's Q3 2017 report, 25 October | ||
| Sobi's Q2 2017 report, 19 July | ||
| Sobi's Q1 2017 report, 28 April | ||
| Sobi's Q4 2016 report, 22 February |
2016
Financial reports presentations
| Sobi's Q3 2016 report, 25 October | ||
| Sobi's Q2 2016 report, 19 July | ||
| Sobi's Q1 2016 report, 28 April |
2014
Investor meetings presentations
| J.P. Morgan investor conference, 14 January |
2013
Investor meetings presentations
| Capital markets day, 5 November |
2012
Investor meetings presentations
| Phase 3 study results Alprolix B-Long, 26 September | ||
| Jefferies investor conference, 5 June | ||
| J.P. Morgan investor conference, 10 January |
2011
Financial reports presentations
| Annual general meeting and Q1 2011 report, 28 April |
Investor meetings presentations
| Capital markets day, 29 November | ||
| Capital markets day, 29 November (video) |
2009
Investor meetings presentations
| Merger of Swedish Orphan International and Biovitrum into Sobi |